Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1995, 718-724, Vol 33, No. 3
TJ O'Leary, MM Tsai, CF Wright and MT Cushion
The use of semiquantitative PCR (SQPCR) to assess Pneumocystis carinii
pneumonia (PCP) infection and its response to treatment was studied with
rats. Groups of eight rats were immunosuppressed with steroids for 3 to 12
weeks. Untreated controls were maintained for the same periods. Three
groups of rats were treated with pentamidine, three groups were treated
with trimethoprim-sulfamethoxazole, and three groups of rats were tapered
from steroids. At various times during suppression, rats from the different
groups were sacrificed. At necropsy, lungs were lavaged to obtain
bronchoalveolar fluids and then homogenized. Bronchoalveolar fluids and
homogenates were assayed by cyst counting and SQPCR. An increase in the
SQPCR signal was seen throughout immunosuppression, with a slow decrease
upon the withdrawal of steroids and a faster decrease with drug treatment.
SQPCR results with lung homogenates and bronchoalveolar fluids strongly
correlated with each other and with cyst counts. These results warrant
investigation of SQPCR for assessing treatment results of human P. carinii
pneumonia infection.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model
Department of Cellular Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|